VAX-MOM COVID-19 Intervention vs Standard of Care: Rate of COVID-19 Vaccination (9 Month)

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

Measures 6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

Measure	Value	95% interval, lower	95% interval, upper	Method	Source
Risk in group 1	0.0949	0.0865	0.104	wilson	ClinicalTrials.gov
Risk in group 2	0.0678	0.0588	0.078	wilson	ClinicalTrials.gov
Risk difference, group 1 minus group 2	0.0271	0.0139	0.0399	newcombe hybrid score	ClinicalTrials.gov
Risk ratio, group 1 over group 2	1.4	1.18	1.66	log	ClinicalTrials.gov
Odds ratio, group 1 over group 2	1.44	1.2	1.73	log	ClinicalTrials.gov
Number needed to treat, for one more participant with the outcome on VAX-MOM COVID-19 Intervention than on Standard of Care	36.9	25	72	from the risk difference interval	ClinicalTrials.gov

Groups 2

Group 2 names the comparator: standard of care.

Group	Title	Description	With the outcome	Analysed	ClinicalTrials.gov code	Source
Group 1	VAX-MOM COVID-19 Intervention	VAX-MOM COVID-19 Intervention: The multi-component VAX-MOM COVID-19 intervention will be comprised of: training in communication, provider prompts, standing orders, and feedback on vaccination rates.	404	4,256	OG000	ClinicalTrials.gov
Group 2	Standard of Care	Standard of Care: Standard vaccine education and processes provided to patients by obstetric practices.	180	2,655	OG001	ClinicalTrials.gov

Outcome 5

Field	Value	Source
Type	SECONDARY	ClinicalTrials.gov
Title	Rate of COVID-19 Vaccination (9 Month)	ClinicalTrials.gov
Description	Average rate of COVID-19 vaccination will be compared between intervention and control arms, for vaccine eligible patients at participating OB/GYN practice sites. Vaccination status will be obtained from patient electronic health records.	ClinicalTrials.gov
Time frame	9 months	ClinicalTrials.gov
Population	9 month cohort	ClinicalTrials.gov

Trial 8

Field	Value	Source
Title	VAX-MOM COVID-19: Increasing Maternal COVID-19 Vaccination	ClinicalTrials.gov
NCT number	NCT05570630	ClinicalTrials.gov
Phases	NA	ClinicalTrials.gov
Conditions	Immunization; Infection, Pregnancy Related, COVID-19	ClinicalTrials.gov
Interventions	VAX-MOM COVID-19 Intervention, Standard of Care	ClinicalTrials.gov
Lead sponsor	University of Rochester	ClinicalTrials.gov
Results first posted	2025-09-04	ClinicalTrials.gov
Results on ClinicalTrials.gov	https://clinicaltrials.gov/study/NCT05570630?tab=results	ClinicalTrials.gov

Source 4

Field	Value	Source
Release	trial-comparisons-2026-03-23-0.1.0	ClinicalTrials.gov
Release manifest SHA-256	f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57	ClinicalTrials.gov
AACT copy	2026-03-23	ClinicalTrials.gov
Tables read	outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet	ClinicalTrials.gov

The same record as JSON

Release trial-comparisons-2026-03-23-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.